The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

Bone Marrow Transplantation
A RovelliC Uderzo

Abstract

Chronic graft-versus-host disease (cGVHD) is a frequent complication of allogeneic bone marrow transplantation (BMT). Thalidomide was found to have immunosuppressive properties and it has been used in a limited number of children with cGVHD. We report our experience with refractory and/or high-risk cGVHD in 14 children. Six children showed complete clinical response to thalidomide in a median time of 2 months. Four children had partial responses and four failed. Side-effects were usually mild (somnolence, constipation) and only two patients developed sensory peripheral neuropathy. An increased incidence of infectious complications attributable to thalidomide was not observed. Nine out of 10 responding patients are alive 49-111 months post-BMT. Thalidomide can be effective particularly in children with prevailing mucocutaneous cGVHD. All patients should be carefully monitored to detect peripheral neuropathy early.

Citations

Jan 13, 2001·Dermatologic Clinics·C L Radomsky, N Levine
May 15, 2012·Bone Marrow Transplantation·Y P L LinharesR P Gale
Mar 20, 2002·Cancer Practice·A M Valorie
May 10, 2001·Journal of Pediatric Gastroenterology and Nutrition·R S Strauss, K M Das
Jan 25, 2005·International Journal of Dermatology·Inacio R FaverRokea el-Azhary
Oct 18, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·C MeierhoferC J Wiedermann
May 3, 2005·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Tomoyuki KabukiTsutomu Oh-Ishi
May 17, 2003·Clinical Therapeutics·S James Matthews, Christopher McCoy
Oct 21, 2003·Leukemia & Lymphoma·M B SteinsR M Mesters
Aug 15, 2003·Leukemia & Lymphoma·Mary E D Flowers, Paul J Martin
Apr 14, 2015·Expert Review of Clinical Immunology·Antonella DiamantiGiuliano Torre
Feb 16, 2005·Expert Opinion on Investigational Drugs·Aristotle Bamias, Meletios A Dimopoulos
Apr 27, 2001·Expert Opinion on Investigational Drugs·D Gaziev, G Lucarelli
Aug 29, 2002·Cancer Investigation·Said BaidasPankaj Bhargava
Mar 24, 2010·Pediatric Clinics of North America·Kristin BairdKirk R Schultz
Aug 10, 2005·The British Journal of Dermatology·J J WuS K Tyring
Apr 12, 2003·Pharmacotherapy·Mark C Okafor
May 15, 2004·British Journal of Haematology·Meghan A Higman, Georgia B Vogelsang
Dec 8, 2005·Pediatric Blood & Cancer·Kenneth L McClain, Claudia A Kozinetz
Apr 27, 2012·British Journal of Haematology·Fiona L DignanUNKNOWN British Society for Blood and Marrow Transplantation
Oct 24, 2009·Clinical Transplantation·Chirag M Pandya, Ayman O Soubani
Jan 18, 2006·Seminars in Hematology·Andrew L Gilman, Jonathan Serody
Oct 7, 2004·The American Journal of Medicine·Meletios A Dimopoulos, Vagelis Eleutherakis-Papaiakovou
Mar 5, 2005·The American Journal of Medicine·Maria J CuadradoGraham R V Hughes
Aug 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffErnst Holler
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeMary E D Flowers
Jan 27, 2015·Journal of the American Academy of Dermatology·Catherine S YangRichard J Antaya
Jan 31, 2002·Annual Review of Medicine·Paul RichardsonKenneth Anderson
Nov 9, 2011·The Korean Journal of Hematology·Paul J MartinMary E D Flowers
Sep 25, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joseph H AntinDaniel Weisdorf
Jan 21, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mukta AroraDaniel J Weisdorf
Jan 18, 2006·Seminars in Hematology·Nelson J Chao, Benny J Chen
Mar 24, 2010·Pediatric Clinics of North America·Paul A Carpenter, Margaret L Macmillan
Mar 16, 2002·The Annals of Pharmacotherapy·Olga Bessmertny, Trinh Pham
Oct 30, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Murali ChintagumpalaStacey L Berg
Aug 19, 2003·The Annals of Pharmacotherapy·Maria R NascaDennis P West
Mar 14, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Marzia LazzeriniAlessandro Ventura
Jan 27, 2004·Bone Marrow Transplantation·S S Farag
Sep 12, 2000·Bone Marrow Transplantation·C PetersUNKNOWN International BFM Study Group--Subcommittee Bone Marrow Transplantation (IBFM-SG)
Nov 18, 2000·Bone Marrow Transplantation·P V BrowneH Enright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
F Carnevale-SchiancaR A Nash
The New England Journal of Medicine
G B VogelsangJ R Wingard
© 2022 Meta ULC. All rights reserved